Skip to main content

$0.220 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
5 June 2026 at 3:51am
Register to track PO3 and receive email alerts.
Subject
PO3 Ann: FRG shows capability of PFAS removal

PO3 Ann: Quarterly Activities Report

PO3 Ann: Appendix 4C Cash Flow Report

PO3 Ann: Appendix 4D - Half Year Report 31 December 2022

PO3 Ann: Suspension from Quotation

PO3 Ann: Appendix 4C Cashflow Report

PO3 Ann: Quarterly Activities Report

PO3 Ann: Results of Meeting

PO3 Ann: Appendix 4C - Quarterly Cashflow Report

PO3 Ann: Quarterly Operations Review

PO3 Ann: AGM Notice - Cover Letter

PO3 Ann: AGM - Proxy Form

PO3 Ann: Notice of Meeting - AGM

PO3 Ann: AGM Date and Director Nominations

PO3 Ann: Annual Report to shareholders

PO3 Ann: Appendix 4E Preliminary Final Results

PO3 Ann: Positive Test Results

PO3 Ann: Change of Share Registry

PO3 Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PO3 Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PO3 Ann: Half Yearly Report and Accounts

PO3 Ann: Appendix 4D 31 December 2021

PO3 Ann: Quarterly Activities Report

PO3 Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PO3 Ann: AGM Voting Results

PO3 Ann: Virtual Meeting Guide

PO3 Ann: Update to AGM Details

PO3 Ann: Virtual Meeting Guide

PO3 Ann: Notice of Meeting AGM

PO3 Ann: Amended Annual Report

PO3 Ann: Operations Review - Quarterly

PO3 Ann: Appendix 3X

PO3 Ann: Reinstatement to official quotation (1/11)

PO3 Ann: Quarterly Appendix 4C Cash Flow Report

PO3 Ann: Notification Required under LR 3.13.1

PO3 Ann: Annual Report to shareholders

PO3 Ann: Suspension from Official Quotation

PO3 Ann: Deferral of Audit

PO3 Ann: Appendix 4E - Preliminary Financial Report

PO3 Ann: Quarterly Operations Review

PO3 Ann: Quarterly Appendix 4C Cash Flow Report

PO3 Ann: Reinstatement to Official Quotation

PO3 Ann: R&D Heads of Agreement with Osmoflo

PO3 Ann: Clarification and Retraction of Media Release

PO3 Ann: Suspension from Official Quotation

PO3 Ann: Trading Halt

PO3 Ann: Pause in Trading

PO3 Ann: Press Release - Hotel Quarantine Issues

PO3 Ann: Presentation to CleanTech Conference

PO3 Ann: Aspen Medical Agreement

Register to track PO3 and receive email alerts.

Similar Companies

D2O
DEM